Laguna, Danilo C.
HRN: 00-53-16 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/11/2025
CEFTAZIDIME 1GM (VIAL)
06/11/2025
06/18/2025
IV
2g
Q8h
CAP-HR, PTB Presumptive
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes